D. Tenen, Disruption of differentiation in human cancer: AML shows the way, Nature Reviews Cancer, vol.4, issue.2, pp.89-101, 2003.
DOI : 10.1038/nrc989

C. Kumar, Genetic Abnormalities and Challenges in the Treatment of Acute Myeloid Leukemia, Genes & Cancer, vol.2, issue.2, pp.95-107, 2011.
DOI : 10.1177/1947601911408076

R. Manfredini, F. Trevisan, A. Grande, E. Tagliafico, M. Montanari et al., Induction of a functional vitamin D receptor in all-trans-retinoic acid-induced monocytic differentiation of M2-type leukemic blast cells, Cancer Res, vol.59, pp.3803-3811, 1999.

Q. Wang, J. Harrison, M. Uskokovic, A. Kutner, and G. Studzinski, Translational study of vitamin D differentiation therapy of myeloid leukemia: effects of the combination with a p38 MAPK inhibitor and an antioxidant, Leukemia, vol.64, issue.10, pp.1812-1817, 2005.
DOI : 10.1074/jbc.M002856200

E. Tagliafico, E. Tenedini, R. Manfredini, A. Grande, F. Ferrari et al., Identification of a molecular signature predictive of sensitivity to differentiation induction in acute myeloid leukemia, Leukemia, vol.65, issue.10, pp.1751-1758, 2006.
DOI : 10.1038/sj.leu.2404358

M. Liu, M. Lee, M. Cohen, M. Bommakanti, and L. Freedman, Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937., Genes & Development, vol.10, issue.2, pp.142-153, 1996.
DOI : 10.1101/gad.10.2.142

M. Asada, T. Yamada, K. Fukumuro, and S. Mizutani, p21Cip1/WAF1 is important for differentiation and survival of U937 cells, Leukemia, vol.12, issue.12, pp.1944-1950, 1998.
DOI : 10.1038/sj.leu.2401228

M. Asada, T. Yamada, H. Ichijo, D. Delia, K. Miyazono et al., Apoptosis inhibitory activity of cytoplasmic p21Cip1/WAF1 in monocytic differentiation, The EMBO Journal, vol.18, issue.5, pp.1223-1234, 1999.
DOI : 10.1093/emboj/18.5.1223

D. Schotte, R. Pieters, D. Boer, and M. , MicroRNAs in acute leukemia: from biological players to clinical contributors, Leukemia, vol.676, issue.1, pp.1-12, 2012.
DOI : 10.2174/138945010791320872

E. Gocek, X. Wang, X. Liu, C. Liu, and G. Studzinski, MicroRNA-32 Upregulation by 1,25-Dihydroxyvitamin D3 in Human Myeloid Leukemia Cells Leads to Bim Targeting and Inhibition of AraC-Induced Apoptosis, Cancer Research, vol.71, issue.19, pp.6230-6239, 2011.
DOI : 10.1158/0008-5472.CAN-11-1717

X. Wang, E. Gocek, C. Liu, and G. Studzinski, MicroRNAs181 regulate the expression of p27Kip1 in human myeloid leukemia cells induced to differentiate by 1,25-dihydroxyvitamin D3, Cell Cycle, vol.8, issue.5, pp.736-741, 2009.
DOI : 10.4161/cc.8.5.7870

M. Delgado and J. León, Myc Roles in Hematopoiesis and Leukemia, Genes & Cancer, vol.1, issue.6, pp.605-616, 2010.
DOI : 10.1177/1947601910377495

S. Adhikary and M. Eilers, Transcriptional regulation and transformation by Myc proteins, Nature Reviews Molecular Cell Biology, vol.17, issue.8, pp.635-645, 2005.
DOI : 10.1073/pnas.0832317100

T. Bui and J. Mendell, Myc: Maestro of MicroRNAs, Genes & Cancer, vol.1, issue.6, pp.568-575, 2010.
DOI : 10.1177/1947601910377491

H. Kitaura, M. Shinshi, Y. Uchikoshi, T. Ono, S. Iguchi-ariga et al., Reciprocal Regulation via Protein-Protein Interaction between c-Myc and p21cip1/waf1/sdi1 in DNA Replication and Transcription, Journal of Biological Chemistry, vol.275, issue.14, pp.10477-10483, 2000.
DOI : 10.1074/jbc.275.14.10477

S. Sander, L. Bullinger, K. Klapproth, K. Fiedler, H. Kestler et al., MYC stimulates EZH2 expression by repression of its negative regulator miR-26a, Blood, vol.112, issue.10, pp.4202-4212, 2008.
DOI : 10.1182/blood-2008-03-147645

B. Salvatori, I. Iosue, D. Damas, N. Mangiavacchi, A. Chiaretti et al., Critical Role of c-Myc in Acute Myeloid Leukemia Involving Direct Regulation of miR-26a and Histone Methyltransferase EZH2, Genes & Cancer, vol.2, issue.5, pp.585-592, 2011.
DOI : 10.1177/1947601911416357

URL : https://hal.archives-ouvertes.fr/pasteur-00976767

T. Chang, D. Yu, Y. Lee, E. Wentzel, D. Arking et al., Widespread microRNA repression by Myc contributes to tumorigenesis, Nature Genetics, vol.121, issue.1, pp.43-50, 2008.
DOI : 10.1038/ng.2007.30

J. Kota, R. Chivukula, O. Donnell, K. Wentzel, E. Montgomery et al., Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer Model, Cell, vol.137, issue.6, pp.1005-1017, 2009.
DOI : 10.1016/j.cell.2009.04.021

Y. Zhu, Y. Lu, Q. Zhang, J. Liu, T. Li et al., MicroRNA-26a/b and their host genes cooperate to inhibit the G1/S transition by activating the pRb protein, Nucleic Acids Research, vol.40, issue.10, pp.4615-4625, 2012.
DOI : 10.1093/nar/gkr1278

J. Lu, M. He, L. Wang, Y. Chen, X. Liu et al., MiR-26a Inhibits Cell Growth and Tumorigenesis of Nasopharyngeal Carcinoma through Repression of EZH2, Cancer Research, vol.71, issue.1, pp.225-233, 2011.
DOI : 10.1158/0008-5472.CAN-10-1850

L. Chen, J. Zheng, Y. Zhang, L. Yang, J. Wang et al., Tumor-specific Expression of MicroRNA-26a Suppresses Human Hepatocellular Carcinoma Growth via Cyclin-dependent and -independent Pathways, Molecular Therapy, vol.19, issue.8, pp.1521-1528, 2011.
DOI : 10.1038/mt.2011.64

B. Westendorp, M. Mokry, G. Koerkamp, M. Holstege, F. Cuppen et al., E2F7 represses a network of oscillating cell cycle genes to control S-phase progression, Nucleic Acids Research, vol.40, issue.8, pp.3511-3523, 2012.
DOI : 10.1093/nar/gkr1203

S. Donzelli, G. Fontemaggi, F. Fazi, D. Agostino, S. Padula et al., MicroRNA-128-2 targets the transcriptional repressor E2F5 enhancing mutant p53 gain of function, Cell Death and Differentiation, vol.63, issue.6, pp.1038-1048, 2012.
DOI : 10.1038/sj.onc.1210294

L. Fontana, E. Pelosi, P. Greco, S. Racanicchi, U. Testa et al., MicroRNAs 17-5p???20a???106a control monocytopoiesis through AML1 targeting and M-CSF receptor upregulation, Nature Cell Biology, vol.4, issue.7, pp.775-787, 2007.
DOI : 10.1128/MCB.01360-05

V. Pospisil, K. Vargova, J. Kokavec, J. Rybarova, F. Savvulidi et al., Epigenetic silencing of the oncogenic miR-17-92 cluster during PU.1-directed macrophage differentiation, The EMBO Journal, vol.205, issue.21, pp.4450-4464, 2011.
DOI : 10.1038/emboj.2011.317

T. Lammens, J. Li, G. Leone, D. Veylder, and L. , Atypical E2Fs: new players in the E2F transcription factor family, Trends in Cell Biology, vol.19, issue.3, pp.111-118, 2009.
DOI : 10.1016/j.tcb.2009.01.002

Q. Deng, Q. Wang, W. Zong, D. Zheng, Y. Wen et al., E2F8 Contributes to Human Hepatocellular Carcinoma via Regulating Cell Proliferation, Cancer Research, vol.70, issue.2, pp.782-791, 2010.
DOI : 10.1158/0008-5472.CAN-09-3082

R. Sozzani, C. Maggio, R. Giordo, E. Umana, J. Ascencio-ibanez et al., The E2FD/DEL2 factor is a component of a regulatory network controlling cell proliferation and development in Arabidopsis, Plant Molecular Biology, vol.136, issue.4-5, pp.381-395, 2010.
DOI : 10.1007/s11103-009-9577-8

M. Hazar-rethinam, S. Cameron, A. Dahler, L. Endo-munoz, L. Smith et al., Loss of E2F7 Expression Is an Early Event in Squamous Differentiation and Causes Derepression of the Key Differentiation Activator Sp1, Journal of Investigative Dermatology, vol.131, issue.5, pp.1077-1084, 2011.
DOI : 10.1038/jid.2010.430

H. Sirma, M. Kumar, J. Meena, B. Witt, J. Weise et al., The Promoter of Human Telomerase Reverse Transcriptase Is Activated During Liver Regeneration and Hepatocyte Proliferation, Gastroenterology, vol.141, issue.1, pp.326-337, 2011.
DOI : 10.1053/j.gastro.2011.03.047

URL : https://hal.archives-ouvertes.fr/hal-00741681

L. Li, A. Sarver, S. Alamgir, and S. Subramanian, Downregulation of microRNAs miR-1, -206 and -29 stabilizes PAX3 and CCND2 expression in rhabdomyosarcoma, Laboratory Investigation, vol.15, issue.4, pp.571-583, 2012.
DOI : 10.1002/1096-911X(200008)35:2<96::AID-MPO2>3.0.CO;2-Z

D. Stefano, L. Jensen, M. Helin, and K. , E2F7, a novel E2F featuring DP-independent repression of a subset of E2F-regulated genes, The EMBO Journal, vol.3, issue.23, pp.6289-6298, 2003.
DOI : 10.1093/emboj/cdg613

J. Christensen, P. Cloos, U. Toftegaard, D. Klinkenberg, A. Bracken et al., Characterization of E2F8, a novel E2F-like cell-cycle regulated repressor of E2F-activated transcription, Nucleic Acids Research, vol.33, issue.17, pp.5458-5470, 2005.
DOI : 10.1093/nar/gki855

P. Wong, M. Iwasaki, T. Somervaille, F. Ficara, C. Carico et al., The miR-17-92 microRNA Polycistron Regulates MLL Leukemia Stem Cell Potential by Modulating p21 Expression, Cancer Research, vol.70, issue.9, pp.3833-3842, 2010.
DOI : 10.1158/0008-5472.CAN-09-3268

I. Ivanovska, A. Ball, R. Diaz, J. Magnus, M. Kibukawa et al., MicroRNAs in the miR-106b Family Regulate p21/CDKN1A and Promote Cell Cycle Progression, Molecular and Cellular Biology, vol.28, issue.7, pp.2167-2174, 2008.
DOI : 10.1128/MCB.01977-07

B. Zhang, X. Liu, J. He, C. Zhou, M. Guo et al., Pathologically decreased miR-26a antagonizes apoptosis and facilitates carcinogenesis by targeting MTDH and EZH2 in breast cancer, Carcinogenesis, vol.32, issue.1, pp.2-9, 2011.
DOI : 10.1093/carcin/bgq209

H. Kim, W. Huang, X. Jiang, B. Pennicooke, P. Park et al., Integrative genome analysis reveals an oncomir/oncogene cluster regulating glioblastoma survivorship, Proceedings of the National Academy of Sciences, vol.107, issue.5, pp.2183-2188, 2010.
DOI : 10.1073/pnas.0909896107

A. Viale, D. Franco, F. Orleth, A. Cambiaghi, V. Giuliani et al., Cell-cycle restriction limits DNA damage and maintains self-renewal of leukaemia stem cells, Nature, vol.58, issue.7225, pp.51-56, 2009.
DOI : 10.1038/35004599

D. Marchis, M. Ballarino, M. Salvatori, B. Puzzolo, M. Bozzoni et al., A new molecular network comprising PU.1, interferon regulatory factor proteins and miR-342 stimulates ATRA-mediated granulocytic differentiation of acute promyelocytic leukemia cells, Leukemia, vol.18, issue.5, pp.856-862, 2009.
DOI : 10.1038/leu.2008.372

A. Rosa and A. Brivanlou, A regulatory circuitry comprised of miR-302 and the transcription factors OCT4 and NR2F2 regulates human embryonic stem cell differentiation, The EMBO Journal, vol.15, issue.2, pp.237-248, 2011.
DOI : 10.1038/emboj.2010.319